Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
44.5M
-
Number of holders
-
26
-
Total 13F shares, excl. options
-
6.48M
-
Shares change
-
-289K
-
Total reported value, excl. options
-
$50.6M
-
Value change
-
-$2.64M
-
Number of buys
-
14
-
Number of sells
-
-10
-
Price
-
$7.82
Significant Holders of TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) as of Q1 2020
30 filings reported holding TELA - TELA Bio, Inc. - Common Stock, par value $0.001 per share as of Q1 2020.
TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) has 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.48M shares
of 44.5M outstanding shares and own 14.54% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (3.03M shares), RTW INVESTMENTS, LP (1.14M shares), Essex Woodlands Management, Inc. (1.07M shares), COWEN AND COMPANY, LLC (406K shares), Alyeska Investment Group, L.P. (197K shares), FEDERATED HERMES, INC. (167K shares), Opaleye Management Inc. (81K shares), Pentwater Capital Management LP (63.3K shares), VANGUARD GROUP INC (50K shares), and MILLENNIUM MANAGEMENT LLC (45.2K shares).
This table shows the top 26 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.